Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

536
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
536
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

725
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
725
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

647
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
647

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of an integrated workflow (NosZRef) for rapid and accurate nosZ gene profiling and its application to oceanic ecosystems.

Marine environmental research·2026
Same author

(In)congruence effect of chronological age and subjective age on older adults' cognitive functioning: the moderating role of social participation and cross-cultural comparisons.

BMC geriatrics·2026
Same author

Recovery of 178 metagenome-assembled genomes from sediments in subterranean estuary.

Scientific data·2026
Same author

Improving Variance and Confidence Interval Estimation in Small-Sample Propensity Score Analyses: Bootstrap Versus Asymptotic Methods.

Statistics in medicine·2026
Same author

Ultra-Broadband Microwave Absorption and Programmable Multispectral Camouflage Enabled by Neural-Network-Driven Impedance-Gradient Metadevices.

Nano-micro letters·2026
Same author

Modeling human B cell development with pluripotent stem cells.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Jun 25, 2025

A High-Throughput Luciferase Assay to Evaluate Proteolysis of the Single-Turnover Protease PCSK9
08:14

A High-Throughput Luciferase Assay to Evaluate Proteolysis of the Single-Turnover Protease PCSK9

Published on: August 28, 2018

8.1K

Cholesterol reduction by immunization with a PCSK9 mimic.

Baoshan Zhang1, Gwo-Yu Chuang1, Andrea Biju1

  • 1Vaccine Research Center, NIAID, National Institutes of Health, Bethesda, MD 20892, USA.

Cell Reports
|May 31, 2024
PubMed
Summary
This summary is machine-generated.

A novel heart attack vaccine mimic, HIT01, targeting proprotein convertase subtilisin/kexin type 9 (PCSK9), effectively lowers cholesterol in animal models. However, it also unexpectedly increases PCSK9 levels, complicating its therapeutic potential.

Keywords:
CP: ImmunologyCP: MetabolismPCSK9cholesterolhalf-lifeimmunogen designlow-density lipoproteinproprotein convertase subtilisin/kexin type 9vaccine

More Related Videos

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

13.3K
A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
10:56

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

8.2K

Related Experiment Videos

Last Updated: Jun 25, 2025

A High-Throughput Luciferase Assay to Evaluate Proteolysis of the Single-Turnover Protease PCSK9
08:14

A High-Throughput Luciferase Assay to Evaluate Proteolysis of the Single-Turnover Protease PCSK9

Published on: August 28, 2018

8.1K
LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

13.3K
A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
10:56

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

8.2K

Area of Science:

  • Biochemistry
  • Immunology
  • Cardiovascular Science

Background:

  • Proprotein convertase subtilisin/kexin type 9 (PCSK9) regulates cholesterol homeostasis.
  • Developing novel strategies to modulate PCSK9 activity is crucial for cardiovascular health.

Purpose of the Study:

  • To design and evaluate a human PCSK9 mimic (HIT01) as a potential vaccine for heart attack prevention.
  • To assess the impact of PCSK9-mimic vaccination on cholesterol levels and PCSK9-directed immune responses.

Main Methods:

  • Design of HIT01, a PCSK9 mimic with no shared 9-residue sequences with human proteins.
  • Murine and cynomolgus macaque immunizations with HIT01 and its variant HIT01-K21Q-R218E.
  • Measurement of low-density lipoprotein (LDL), cholesterol, and PCSK9 serum levels.

Main Results:

  • HIT01 vaccination reduced LDL and cholesterol levels by 40% and 30% in mice.
  • HIT01-K21Q-R218E vaccination in macaques induced high-titer PCSK9 antibodies and reduced cholesterol.
  • PCSK9-binding antibodies increased serum PCSK9 levels up to 5-fold, suggesting altered PCSK9 half-life.

Conclusions:

  • Vaccination with a PCSK9 mimic can induce potent PCSK9-directed antibodies and lower cholesterol.
  • PCSK9-binding antibodies may alter PCSK9 homeostasis, impacting vaccine efficacy.
  • This study suggests a novel mechanism for extending the half-life of soluble regulatory factors via vaccination.